Search results
Results from the WOW.Com Content Network
List of Antiviral Drugs Antiviral Use Manufacturer Component Type Year approved Abacavir: HIV: ViiV Healthcare: Nucleoside analogue reverse transcriptase inhibitor (NRTI) 1998 Acyclovir (Aciclovir) Herpes Simplex, chickenpox, [2] varicella zoster virus: GSK: guanosine analogue RTI 1981 Adefovir: Hepatitis B [3] Gilead Sciences RTI 2002 , 2003 ...
Most infections are mild and require no therapy or only symptomatic treatment. Under research [1] Trypanosoma brucei: African sleeping sickness (African trypanosomiasis) Identification of trypanosomes in a sample by microscopic examination Fexinidazole by mouth or pentamidine by injection for T. b. gambiense.
Antiviral drugs are a class of medication used for treating viral infections. [1] Most antivirals target specific viruses , while a broad-spectrum antiviral is effective against a wide range of viruses. [ 2 ]
A viral disease (or viral infection) occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells. [ 1 ] Examples are the common cold , gastroenteritis and pneumonia .
Antiviral drugs (5 C, 134 P) A. Animal viral diseases (18 C, 210 P) C. Coronavirus-associated diseases (5 C, 10 P) E. ... Human betaherpesvirus 5; I. Imjin thottimvirus;
The first list was published in 1977 and included 208 medications. [8] [2] [9] The WHO updates the list every two years. [10] There are 306 medications in the 14th list in 2005, [11] 410 in the 19th list in 2015, [10] 433 in the 20th list in 2017, [12] [13] 460 in the 21st list in 2019, [14] [15] [16] and 479 in the 22nd list in 2021.
Similar to the way doctors use antifungals to treat fungal infections in humans, farmers use fungicides, a type of pesticide, to kill fungal diseases that overtake crops.
Nitazoxanide alone has shown preliminary evidence of efficacy in the treatment of chronic hepatitis B over a one-year course of therapy. [17] Nitazoxanide 500 mg twice daily resulted in a decrease in serum HBV DNA in all of 4 HBeAg-positive patients, with undetectable HBV DNA in 2 of 4 patients, loss of HBeAg in 3 patients, and loss of HBsAg in one patient.